Posted by Michael Wonder on 23 Nov 2016
NICE recommends extra ‘triple therapy’ drug for treating type 2 diabetes
23 November 2016 - NICE has published final guidance recommending dapagliflozin for treating type 2 diabetes in ‘triple therapy’.
Dapagliflozin can be added as a third drug where two drugs for type 2 diabetes are not controlling a person’s blood sugar level.
